Some biopharma researchers are using artificial intelligence to identify unique brain signatures of Alzheimer’s disease, and to discover biomarkers in blood samples that can be used to personalize cancer treatments. Others are deploying gene-editing tools, advanced analytics and new imaging technologies to uncover new biomarkers that can improve the diagnosis and treatment of a range of diseases.
This Fierce webinar will feature executives from leading biopharma companies and technology-development firms, who will describe the latest tools and techniques for improving biomarker discovery. They will discuss how they chose and deployed these technologies, provide examples of how they led to the discovery of novel biomarkers, and offer tips for selecting tools to aid in biomarker discovery and incorporating them into established R&D processes.
- How CRISPR and other gene-editing technologies can be used to uncover new biomarkers across a range of diseases.
- New tools that combine proteomics and genomics to aid the discovery of biomarkers in cancer.
- Applying artificial intelligence to CT scans and other medical imagery to generate visual biomarkers for diagnosing diseases and tracking the effectiveness of treatments over time.